PAI
Palo Alto Investors Portfolio holdings
AUM
$470M
This Quarter Return
-11.21%
1 Year Return
+2.57%
3 Year Return
+93.77%
5 Year Return
+190.64%
10 Year Return
+955.02%
AUM
$1.5B
AUM Growth
+$1.5B
(-27%)
Cap. Flow
-$199M
Cap. Flow
% of AUM
-13.23%
Top 10 Holdings %
Top 10 Hldgs %
68.56%
Holding
39
New
–
Increased
–
Reduced
23
Closed
2
Top Buys
No buys this quarter
Top Sells
| 1 |
Exact Sciences
EXAS
|
$37.2M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$26.8M |
| 3 |
SAGE
Sage Therapeutics
SAGE
|
$16M |
| 4 |
Insmed
INSM
|
$11.5M |
| 5 |
United Therapeutics
UTHR
|
$10.2M |
Sector Composition
| 1 | Healthcare | 87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
BioMarin Pharmaceuticals
BMRN
$11.2B
| $149M | 9.92% | 2,209,504 -396,981 | -15% | -$26.8M |
|
|
2
Insmed
INSM
$28.8B
| $128M | 8.51% | 7,239,649 -651,268 | -8% | -$11.5M |
|
|
ABMD
3
DELISTED
Abiomed Inc
ABMD
| $116M | 7.75% | 654,428 -51,926 | -7% | -$9.24M |
|
|
4
United Therapeutics
UTHR
$13.8B
| $114M | 7.57% | 1,424,401 -128,391 | -8% | -$10.2M |
|
5
STAAR Surgical
STAA
$1.36B
| $100M | 6.68% | 3,890,693 -346,358 | -8% | -$8.93M |
|
|
SAGE
6
DELISTED
Sage Therapeutics
SAGE
| $95.5M | 6.36% | 680,894 -114,137 | -14% | -$16M |
|
|
ALXN
7
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $93.8M | 6.25% | 957,950 -65,830 | -6% | -$6.45M |
|
|
IMMU
8
DELISTED
Immunomedics Inc
IMMU
| $82M | 5.46% | 6,184,320 -492,435 | -7% | -$6.53M |
|
9
Acadia Pharmaceuticals
ACAD
$4.38B
| $78.3M | 5.22% | 2,176,677 -132,126 | -6% | -$4.76M |
|
|
AIMT
10
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $72.7M | 4.84% | 3,471,740 -356,824 | -9% | -$7.47M |
|
|
EPZM
11
DELISTED
Epizyme, Inc
EPZM
| $65.5M | 4.37% | 6,354,659 -580,415 | -8% | -$5.99M |
|
12
Vanda Pharmaceuticals
VNDA
$279M
| $60.8M | 4.05% | 4,581,176 -473,874 | -9% | -$6.29M |
|
13
Amicus Therapeutics
FOLD
$2.34B
| $57.4M | 3.83% | 7,162,920 -633,379 | -8% | -$5.08M |
|
|
WMGI
14
DELISTED
Wright Medical Group Inc
WMGI
| $51.5M | 3.43% | 2,494,255 -277,139 | -10% | -$5.72M |
|
15
Karyopharm Therapeutics
KPTI
$61.7M
| $46.6M | 3.1% | 4,842,150 -420,113 | -8% | -$4.04M |
|
|
AMAG
16
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $35.6M | 2.37% | 3,078,874 -296,632 | -9% | -$3.43M |
|
|
ALDR
17
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $35.1M | 2.34% | 1,861,630 | – | – |
|
18
Align Technology
ALGN
$10.3B
| $26.7M | 1.78% | 147,505 | – | – |
|
|
MNTA
19
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $22.8M | 1.52% | 1,757,122 -162,191 | -8% | -$2.1M |
|
|
CLVS
20
DELISTED
Clovis Oncology, Inc.
CLVS
| $18.6M | 1.24% | 4,720,744 -420,560 | -8% | -$1.65M |
|
21
Puma Biotechnology
PBYI
$254M
| $15.1M | 1.01% | 1,405,680 | – | – |
|
22
Prothena Corp
PRTA
$441M
| $7.88M | 0.52% | 1,004,449 -104,061 | -9% | -$816K |
|
23
Rigel Pharmaceuticals
RIGL
$697M
| $6.71M | 0.45% | 3,587,351 -398,594 | -10% | -$745K |
|
|
KLDO
24
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
| $5.93M | 0.4% | 787,999 -78,667 | -9% | -$592K |
|
|
DRNA
25
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $4.77M | 0.32% | 331,813 | – | – |
|